Angiopoietin-like growth factor-derived peptides as biological activators of adipose-derived mesenchymal stromal cells - 23/07/24
Abstract |
Adipose-derived mesenchymal stromal cells (AD-MSCs) are an essential issue in modern medicine. Extensive preclinical and clinical studies have shown that mesenchymal stromal/stem cells, including AD-MSCs, have specific properties (ability to differentiate into other cells, recruitment to the site of injury) of particular importance in the regenerative process. Ongoing research aims to elucidate factors supporting AD-MSC culture and differentiation in vitro. Angiopoietin-like proteins (ANGPTLs), known for their pleiotropic effects in lipid and glucose metabolism, may play a significant role in this context. Regeneration is a complex and dynamic process controlled by many factors. ANGPTL6 (Angiopoietin-related growth factor, AGF), among many activities modulated the biological activity of stem cells. This study examined the influence of synthesized AGF-derived peptides, designated as AGF9 and AGF27, on AD-MSCs. AGF9 and AGF27 enhanced the viability and migration of AD-MSCs and acted as a chemotactic factor for these cells. AGF9 stimulated chondrogenesis and lipid synthesis during AD-MSCs differentiation, influenced AD-MSCs cytokine secretion and modulated transcriptome for such basic cell activities as migration, transport of molecules, and apoptosis. The ability of AGF9 to modulate the biological activity of AD-MSCs warrants the consideration of this peptide a noteworthy therapeutic agent that deserves further investigation for applications in regenerative medicine.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Angiopoietin-like growth factor-derived peptides modulate AD-MSCs activities. |
• | AGF9 affects adipogenesis and differentiation into osteocytes (osteogenesis). |
• | AGF9 stimulates the chondrogenesis process. |
• | AD-MSCs transcriptomic response to AGF9 changes some related biological processes. |
• | AGF9 peptide is a potential medicinal product for use in the regeneration process. |
Abbreviations : AD-MSCs, MSCs, AGF, ANGPTLs, RGD, GAG
Keywords : Adipose-derived mesenchymal stromal cells, AD-MSCs, Angiopoietin-like proteins, AGF-derived peptides, AGF, ANGPTL6
Plan
Vol 177
Article 117052- août 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?